| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ALT over the last quarter tilts toward buying: insiders added a net 15,000 shares worth roughly $44K.
Classified under Biotechnology (Health Care sector), ALT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 424.5K | $1.30M | - | |
| Other | 113.7K | $274.5K | - | |
| Other | 70.1K | $215.2K | - | |
| CEO | 62.5K | $184.4K | - | |
| CFO | 49.9K | $137.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2018 | Pisano Wayne67 | Director | Buy | 2,000 | $4.59 | $9,180.00 | New | |
| May 25, 2018 | Enright William | President and CEO | Buy | 1,300 | $0.51 | $659.88 | +0.4% | |
| Dec 29, 2017 | Sayare Mitchel | Director | Buy | 5,100 | $1.95 | $9,962.85 | +18.5% | |
| Dec 29, 2017 | Schaffer Derace L | Director | Buy | 97,410 | $1.92 | $187,450.36 | +19.8% | |
| Dec 27, 2017 | Schaffer Derace L | Director | Buy | 147,130 | $1.76 | $259,356.40 | +42.7% | |
| Dec 7, 2017 | Schaffer Derace L | Director | Buy | 23,745 | $1.78 | $42,303.53 | +7.4% | |
| Dec 5, 2017 | Schaffer Derace L | Director | Buy | 26,010 | $1.79 | $46,587.57 | +8.8% | |
| Nov 30, 2017 | Schaffer Derace L | Director | Buy | 33,315 | $1.91 | $63,638.65 | +12.7% | |
| Nov 27, 2017 | Schaffer Derace L | Director | Buy | 21,808 | $2.03 | $44,282.19 | +9.1% | |
| Nov 21, 2017 | Schaffer Derace L | Director | Buy | 18,331 | $2.08 | $38,214.73 | +8.3% |